passing out on semaglutide Woman shares journey of weight loss and gain after using How Does Semaglutide Work to

Study 1: STEP-1 Trial (Obesity) Published in The New England Journal of Medicine , the STEP-1 trial found that adults with obesity or overweight who received weekly semaglutide injections lost an average of about 15% of their body weight over 68 weeks, compared with just 2.4% in the placebo group

In comparison, insurance companies typically do not cover Wegovy when used for weight management, as it is not considered a medically necessary treatment

3 Are you scaling or introducing medical weight loss services in your practice

Most patients will see this clinic as legitimate, with a few caveats worth knowing

For those shopping for the most cost-effective option, our guide to affordable compounded tirzepatide compares pricing and value across multiple providers